Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.

Frontiers in immunology - 1 Jan 2021

Hao Zhixing, Lin Mingjie, Du Feng, Xin Zhongwei, Wu Dang, Yu Qun, Wu Yimin, Zhu Zhouyu, Li Wenshan, Chen Yongyuan, Chen Xiaoke, Chai Ying, Jin Shenghang, Wu Pin

Abstract excerpt

Background: Systemic immune dysregulation correlates with cancer progression. However, the clinical implications of systemic immune dysregulation in early non-small cell lung cancer (NSCLC) remain unclear. Methods: Using a panel of 9 markers to identify 12 parameters in the peripheral blood of 326 patients (34 in the discovery group and 292 in the validation group), we investigated systemic immune dysregulation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to CD4-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Differentiation

Share to ErbB Receptors

Share to Immunotherapy

Share to Lung Neoplasms

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 35116020
DOI: 10.3389/fimmu.2021.754138
PMCID: PMC8804248

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.PMID 35116020Read ↗

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patientsSemantic proximity Read ↗

Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancerSemantic proximity Read ↗

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancerSemantic proximity Read ↗

Characterizing heterogeneity of non-small cell lung tumour microenvironment to identify signature prognostic genes.Semantic proximity Read ↗

Differential expression of immune-regulatory proteins C5AR1, CLEC4A and NLRP3 on peripheral blood mononuclear cells in early-stage non-small cell lung cancer patientsSemantic proximity Read ↗

Immune Infiltration Profiling in Nonsmall Cell Lung Cancer and Their Clinical Significance: Study Based on Gene Expression MeasurementsSemantic proximity Read ↗

Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Differential Expression of Immune-Regulatory Protein C5AR1, NLRP3 and CLEC4A on Peripheral Blood Mononuclear Cells in Early-Stage Non-Small Cell Lung Cancer PatientsSemantic proximity Read ↗

Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancerSemantic proximity Read ↗

Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma.Semantic proximity Read ↗

Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.Semantic proximity Read ↗

Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.